Skip to content

Application of hyaluronic acid enriched transfer media in thawed single blastocyst transfer in advanced maternal age infertile patients: a single center randomized controlled trial

Application of hyaluronic acid enriched transfer media in thawed single blastocyst transfer in advanced maternal age infertile patients: a single center randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500095476
Enrollment
Unknown
Registered
2025-01-08
Start date
2025-02-01
Completion date
Unknown
Last updated
2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

Sponsors

Jiangxi Maternal and Child Health Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
35 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1) The age of the female party is >= 35 years old; 2) Using natural cycles, modified natural cycles, hormone replacement cycles, or downregulated hormone replacement cycles for endometrial preparation; 3) This cycle chooses to transfer single blastocyst.

Exclusion criteria

Exclusion criteria: 1) Patients with contraindications to assisted reproductive technology or pregnancy; 2) Fresh cycle refers to patients with PGT cycle or chromosomal abnormalities in one spouse; 3) Sperm or egg donate cycle; 4) Mixed cycle and sequential transfer cycle; 5) People who have habits of excessive drinking, smoking, and drug abuse; 6) Patients participating in other clinical studies.

Design outcomes

Primary

MeasureTime frame
live birth rate;

Secondary

MeasureTime frame
clinical pregnancy rate;embryo implantation rate;early miscarriage rate;

Countries

China

Contacts

Public ContactXingwu Wu

Jiangxi Maternal and Child Health Hospital

wuxingwujy@163.com+86 159 7061 1041

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026